Ferroglobe PLC Schedules Third Quarter 2025 Earnings Call for November 6, 2025

(NASDAQ:GSM), LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025, and will host the quarterly earnings call on Thursday, November 6, 2025, at 8:30 a.m. Eastern Time. To join via phone: Conference call […]

CEA Industries ($BNC) Crosses Half-Million BNB Milestone

(NASDAQ:BNC),(NASDAQ:BNCWW), Louisville, CO, Oct. 21, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”) today announced that it now holds a total of 500,000 BNB tokens, with an average acquisition cost of approximately $870 per BNB, representing a total invested amount of $435 million and an estimated BNB value of $546.8million

PetVivo Holdings, Inc. Addresses Veterinary Industry’s GEN Z Problem With Breakthrough AI License Agreement

(Other OTC:PETV),(OTC US:PETV),(OTC US:PETVW),(Other OTC:PETVW), MINNEAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., an emerging biomedical device company focused on the commercialization of groundbreaking medical products for horses and companion animals, today announced it has entered into an exclusive

Atossa Therapeutics Highlights Progress in RECAST™ DCIS Platform Trial at Early Detection Research Conference; Laura Esserman, MD, MBA, to Discuss Active-Surveillance Strategy and Novel Endocrine Agents

Investor-focused update underscores enrollment momentum, biomarker strategy, and near-term data readouts designed to de-risk development of (Z)-Endoxifen and other endocrine therapies for DCIS Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD, MBA, Professor of Surgery and Radiology at

SharpLink Reports Total ETH Holdings Rise to 859,853 as of October 19, 2025; Total ETH and Cash Holdings of $3.5 Billion

(NASDAQ:SBET), Minneapolis, MN, Oct. 21, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced that as of October 19, 2025, SharpLink's total ETH holdings increased to 859,8531, reflecting the Company's continued commitment

Solenic Medical Announces Successful Use of Its AMF Technology Under FDA Compassionate Use Authorization

DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today announced the successful, FDA-authorized compassionate use of its investigational Alternating Magnetic Field (AMF) technology. The noninvasive AMF treatment was delivered as an adjunct to surgery in a patient with a serious medical condition

AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure

Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association (NYHA) Class III heart failure No adverse events were deemed related to AB-1002, and clinically meaningful improvement of several efficacy assessments was seen in

SunPower Announces Record Profit in Q3’25

(NasdaqGM:CSLR),(NasdaqGM:SPWR),(NASDAQ:SPWRW), OREM, Utah, Oct. 21, 2025 (GLOBE NEWSWIRE) — SunPower, the “Company,” or Nasdaq: “SPWR”, a solar technology, services, and installation company, will present its Q3'25 results via webcast today Tuesday, October 21 at 1:00pm ET. Interested parties may access the webcast by registering here or by visiting the Events page within the IR section

NIH Grant Awarded to Further Research of Novel Chemical Pathway to Reverse MCI

SAN FRANCISCO, Oct. 21, 2025 (GLOBE NEWSWIRE) — The NIH has awarded a new grant to Posit Science, the maker of the online BrainHQ brain exercises, to advance research, which showed in a neuro-imaging study published last week, that their brain exercises can significantly upregulate the production of a key brain chemical (acetylcholine) – known

Playtika Announces Date of Third Quarter 2025 Results Conference Call

(NASDAQ:PLTK), HERZLIYA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) — Playtika Holding Corp. (NASDAQ:PLTK) announced today that it will release financial results for the third quarter of 2025 before U.S. markets open on Thursday, November 6, 2025. On the same day, Playtika management will hold a conference call to discuss the results at 5:30 AM Pacific

Scroll to Top